We showed that SOCS2 overexpression in macrophages suppresses NASH development via limiting inflammation and apoptosis, while SOCS2 knock-down in macrophages aggravates NASH progression by promoting inflammation and apoptosis. Here, SOCS2 is linked to metabolic dysfunction-associated steatohepatitis.